WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$3.17
+1.28%0
Insider buys (3m)
4
Insider sells (3m)
-$135.1K
Net value (3m)
-44.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 7, 2026 | HENRY CHRISTIAN O · director | A-Award | 64,000 | $3.75 |
| Oct 7, 2026 | CORRIGAN MARK · director | A-Award | 64,000 | $3.75 |
| Oct 7, 2026 | Tan Aik Na · director | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | Wagner Heidi L · director | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | Rawcliffe Adrian · director | A-Award | 64,000 | $3.75 |
| Oct 7, 2026 | Verdine Gregory L. · director | A-Award | 64,000 | $3.75 |
| Oct 7, 2026 | CORRIGAN MARK · director | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | TAKANASHI KEN · director | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | Verdine Gregory L. · director | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | Wagner Heidi L · director | A-Award | 64,000 | $3.75 |
| Oct 7, 2026 | Rawcliffe Adrian · director | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | Tan Aik Na · director | A-Award | 64,000 | $3.75 |
| Oct 7, 2026 | HENRY CHRISTIAN O · director | A-Award | 10,700 | $0.00 |
| Oct 7, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 64,000 | $3.75 |
| Oct 7, 2026 | TAKANASHI KEN · director | A-Award | 64,000 | $3.75 |
| Aug 13, 2026 | Wagner Heidi L · director | M-Exempt | 7,000 | $5.97 |
| Aug 13, 2026 | Tan Aik Na · director | Sale | 432 | $6.01 |
| Aug 13, 2026 | Wagner Heidi L · director | Sale | 7,000 | $6.01 |
| Aug 13, 2026 | Rawcliffe Adrian · director | Sale | 12,700 | $5.29 |
| Aug 13, 2026 | TAKANASHI KEN · director | Sale | 3,864 | $6.01 |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 351,224 | $6.38 |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 4,954,558 | $6.06 |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 971,091 | $6.50 |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 2,495,623 | $6.43 |
| Feb 27, 2026 | Francis Chris · officer: See Remarks | Sale | 15,294 | $15 |
| Feb 27, 2026 | Francis Chris · officer: See Remarks | M-Exempt | 15,294 | $4.75 |
| Feb 27, 2026 | Francis Chris · officer: See Remarks | Sale | 17,900 | $15 |
| Feb 27, 2026 | Francis Chris · officer: See Remarks | M-Exempt | 17,900 | $3.87 |
| Feb 11, 2026 | Francis Chris · officer: See Remarks | A-Award | 232,500 | $13 |
Institutional positioning
13F filings over the trailing two quarters
New 99Increased 200Reduced 103Sold out 54
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Increased | 26,975,505 | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 26,975,505 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 19,202,461 | Aug 7, 2026 |
| GSK PLC | Unchanged | 18,245,691 | May 14, 2026 |
| GSK plc | Unchanged | 18,245,691 | Aug 13, 2026 |
| BLACKROCK, INC. | Increased | 14,117,412 | May 13, 2026 |
| MAVERICK CAPITAL LTD | Increased | 11,317,399 | May 15, 2026 |
| MAVERICK CAPITAL LTD | Reduced | 10,278,115 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 8,704,550 | May 15, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 5,443,143 | Aug 14, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Reduced | 5,431,021 | May 15, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 5,354,622 | Aug 14, 2026 |
| FEDERATED HERMES, INC. | Increased | 5,317,457 | May 11, 2026 |
| FMR LLC | Reduced | 5,192,761 | May 15, 2026 |
| 683 Capital Management, LLC | Increased | 4,950,000 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 7, 2026